Summary

for males ages 18-99 (full criteria)
healthy people welcome
study started
estimated completion
Jaime Landman

Description

Summary

The purpose of this study is to compare changes in the body's self-defense (immune response) after two different treatments for small kidney tumors: 1) Cryoablation (freezing) therapy in which the tumor and a margin of normal kidney tissue are frozen and thawed twice with a needle probe and 2) radiofrequency ablation (RFA) in which radiofrequency energy delivered through a needle probe is used to heat tissue and thereby destroy a tumor.

Keywords

Immune Response to 3 Approaches Carcinoma, Renal Cell

Eligibility

You can join if…

Open to males ages 18-99

  • You are eligible to participate in this study if you are an adult (older than 18 years)
  • Diagnosed with renal cell cancer 1-3 centimeters in size on the CT scan.

You CAN'T join if...

  • You are not eligible to participate in this study if you are immune compromised (chemotherapy,corticosteroid use, HIV [as documented in your medical record], etc.)
  • Have an autoimmune disorders (Rheumatoid arthritis, Crohn's disease, etc)
  • Have a tumor larger than 4 cm
  • Are pregnant.

Lead Scientist

  • Jaime Landman
    Professor, Urology. Authored (or co-authored) 255 research publications

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Irvine
ID
NCT03409224
Study Type
Observational
Last Updated